Difficult-to-treat Behçet syndrome : A therapeutic approach

Copyright © 2023 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 249(2023) vom: 15. Apr., Seite 109272
1. Verfasser: Yazici, Yusuf (VerfasserIn)
Weitere Verfasser: Hatemi, Gulen
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2023
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Review Journal Article Azathioprine Behcet syndrome Disease activity Outcomes Personalized medicine
LEADER 01000naa a22002652 4500
001 NLM353284963
003 DE-627
005 20231226055637.0
007 cr uuu---uuuuu
008 231226s2023 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2023.109272  |2 doi 
028 5 2 |a pubmed24n1177.xml 
035 |a (DE-627)NLM353284963 
035 |a (NLM)36822253 
035 |a (PII)S1521-6616(23)00051-7 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Yazici, Yusuf  |e verfasserin  |4 aut 
245 1 0 |a Difficult-to-treat Behçet syndrome  |b A therapeutic approach 
264 1 |c 2023 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 04.04.2023 
500 |a Date Revised 11.04.2023 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2023 Elsevier Inc. All rights reserved. 
520 |a Behcet syndrome is a systemic vasculitis which can involve many different organ systems. As such, treatment decisions need to be based on organ system involved. In addition, specific patient characteristics potentially predict milder or more severe course, and all these factors need to be taken into consideration when making treatment decisions. In this paper, we review the current approaches to treating Behcet syndrome patients 
650 4 |a Review 
650 4 |a Journal Article 
650 4 |a Azathioprine 
650 4 |a Behcet syndrome 
650 4 |a Disease activity 
650 4 |a Outcomes 
650 4 |a Personalized medicine 
700 1 |a Hatemi, Gulen  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 249(2023) vom: 15. Apr., Seite 109272  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:249  |g year:2023  |g day:15  |g month:04  |g pages:109272 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2023.109272  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 249  |j 2023  |b 15  |c 04  |h 109272